Annual CFO
-$9.97 M
+$587.00 K+5.56%
31 December 2023
Summary:
BioCardia annual cash flow from operations is currently -$9.97 million, with the most recent change of +$587.00 thousand (+5.56%) on 31 December 2023. During the last 3 years, it has risen by +$2.38 million (+19.28%). BCDA annual CFO is now -3113.29% below its all-time high of $331.00 thousand, reached on 31 December 2015.BCDA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.61 M
-$1.30 M-99.01%
30 September 2024
Summary:
BioCardia quarterly cash flow from operations is currently -$2.61 million, with the most recent change of -$1.30 million (-99.01%) on 30 September 2024. Over the past year, it has dropped by -$199.00 thousand (-8.25%). BCDA quarterly CFO is now -146.92% below its all-time high of $5.57 million, reached on 30 September 2016.BCDA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$7.30 M
-$199.00 K-2.80%
30 September 2024
Summary:
BioCardia TTM cash flow from operations is currently -$7.30 million, with the most recent change of -$199.00 thousand (-2.80%) on 30 September 2024. Over the past year, it has increased by +$3.82 million (+34.32%). BCDA TTM CFO is now -227.89% below its all-time high of $5.71 million, reached on 30 September 2016.BCDA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCDA Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.6% | -8.3% | +34.3% |
3 y3 years | +19.3% | +1.2% | +32.4% |
5 y5 years | +9.9% | -77.4% | +22.6% |
BCDA Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +19.3% | -99.0% | +17.1% | -2.8% | +35.9% |
5 y | 5 years | -5.6% | +19.3% | -99.0% | +27.6% | -2.8% | +40.9% |
alltime | all time | -3113.3% | +19.3% | -146.9% | +76.5% | -227.9% | +57.7% |
BioCardia Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$2.61 M(+99.0%) | -$7.30 M(+2.8%) |
June 2024 | - | -$1.31 M(-14.2%) | -$7.11 M(-20.6%) |
Mar 2024 | - | -$1.53 M(-17.3%) | -$8.94 M(-10.3%) |
Dec 2023 | -$9.97 M(-5.6%) | -$1.85 M(-23.3%) | -$9.97 M(-10.3%) |
Sept 2023 | - | -$2.41 M(-23.5%) | -$11.12 M(+3.8%) |
June 2023 | - | -$3.15 M(+23.1%) | -$10.71 M(+5.0%) |
Mar 2023 | - | -$2.56 M(-14.6%) | -$10.21 M(-3.3%) |
Dec 2022 | -$10.56 M(+1.9%) | -$3.00 M(+49.4%) | -$10.56 M(+0.2%) |
Sept 2022 | - | -$2.01 M(-24.2%) | -$10.54 M(-5.7%) |
June 2022 | - | -$2.65 M(-9.2%) | -$11.18 M(-1.9%) |
Mar 2022 | - | -$2.91 M(-2.1%) | -$11.40 M(+9.9%) |
Dec 2021 | -$10.37 M(-16.1%) | -$2.98 M(+12.6%) | -$10.37 M(-4.1%) |
Sept 2021 | - | -$2.64 M(-7.7%) | -$10.81 M(-8.2%) |
June 2021 | - | -$2.87 M(+52.2%) | -$11.77 M(+4.6%) |
Mar 2021 | - | -$1.88 M(-44.9%) | -$11.25 M(-9.0%) |
Dec 2020 | -$12.36 M(+30.8%) | -$3.42 M(-5.2%) | -$12.36 M(+1.3%) |
Sept 2020 | - | -$3.60 M(+53.8%) | -$12.20 M(+21.2%) |
June 2020 | - | -$2.34 M(-21.7%) | -$10.06 M(+0.9%) |
Mar 2020 | - | -$2.99 M(-8.1%) | -$9.97 M(+5.6%) |
Dec 2019 | -$9.45 M(-14.7%) | -$3.26 M(+121.2%) | -$9.45 M(+0.1%) |
Sept 2019 | - | -$1.47 M(-34.6%) | -$9.44 M(-5.4%) |
June 2019 | - | -$2.25 M(-8.6%) | -$9.97 M(-5.0%) |
Mar 2019 | - | -$2.46 M(-24.1%) | -$10.50 M(-5.2%) |
Dec 2018 | -$11.07 M(+27.7%) | -$3.25 M(+61.6%) | -$11.07 M(+7.0%) |
Sept 2018 | - | -$2.01 M(-27.7%) | -$10.35 M(+2.3%) |
June 2018 | - | -$2.78 M(-8.5%) | -$10.12 M(+7.3%) |
Mar 2018 | - | -$3.04 M(+20.2%) | -$9.43 M(+8.7%) |
Dec 2017 | -$8.67 M(+57.0%) | -$2.52 M(+42.1%) | -$8.67 M(-49.8%) |
Sept 2017 | - | -$1.78 M(-15.0%) | -$17.27 M(+74.0%) |
June 2017 | - | -$2.09 M(-8.2%) | -$9.92 M(+25.8%) |
Mar 2017 | - | -$2.28 M(-79.5%) | -$7.88 M(+42.8%) |
Dec 2016 | -$5.52 M(-1768.3%) | -$11.12 M(-299.8%) | -$5.52 M(-196.7%) |
Sept 2016 | - | $5.57 M(<-9900.0%) | $5.71 M(+3003.8%) |
June 2016 | - | -$53.00 K(-162.4%) | $184.00 K(-43.7%) |
Mar 2016 | - | $85.00 K(-25.4%) | $327.00 K(-1.2%) |
Dec 2015 | $331.00 K(+54.7%) | $114.00 K(+200.0%) | $331.00 K(+22.6%) |
Sept 2015 | - | $38.00 K(-57.8%) | $270.00 K(-5.9%) |
June 2015 | - | $90.00 K(+1.1%) | $287.00 K(+4.0%) |
Mar 2015 | - | $89.00 K(+67.9%) | $276.00 K(+29.0%) |
Dec 2014 | $214.00 K(+692.6%) | $53.00 K(-3.6%) | $214.00 K(+10.9%) |
Sept 2014 | - | $55.00 K(-30.4%) | $193.00 K(+46.2%) |
June 2014 | - | $79.00 K(+192.6%) | $132.00 K(+94.1%) |
Mar 2014 | - | $27.00 K(-15.6%) | $68.00 K(+151.9%) |
Dec 2013 | $27.00 K(-108.7%) | $32.00 K(-633.3%) | $27.00 K(-93.9%) |
Sept 2013 | - | -$6000.00(-140.0%) | $440.00 K(+14.3%) |
June 2013 | - | $15.00 K(-207.1%) | $385.00 K(-229.2%) |
Mar 2013 | - | -$14.00 K(-103.1%) | -$298.00 K(-3.9%) |
Dec 2012 | -$310.00 K(-90.0%) | $445.00 K(-829.5%) | -$310.00 K(-80.2%) |
Sept 2012 | - | -$61.00 K(-90.9%) | -$1.56 M(+10.5%) |
June 2012 | - | -$668.00 K(+2469.2%) | -$1.42 M(-44.6%) |
Mar 2012 | - | -$26.00 K(-96.8%) | -$2.56 M(-17.2%) |
Dec 2011 | -$3.09 M(-27.8%) | -$809.00 K(-1029.9%) | -$3.09 M(+8.4%) |
Sept 2011 | - | $87.00 K(-104.8%) | -$2.85 M(-29.7%) |
June 2011 | - | -$1.81 M(+223.8%) | -$4.05 M(+3.8%) |
Mar 2011 | - | -$558.00 K(-2.1%) | -$3.90 M(-8.8%) |
Dec 2010 | -$4.28 M | -$570.00 K(-48.8%) | -$4.28 M(-12.0%) |
Sept 2010 | - | -$1.11 M(-32.8%) | -$4.86 M(-6.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2010 | - | -$1.66 M(+77.3%) | -$5.17 M(+9.2%) |
Mar 2010 | - | -$935.00 K(-18.9%) | -$4.74 M(-1.0%) |
Dec 2009 | -$4.78 M(+77.4%) | -$1.15 M(-19.0%) | -$4.78 M(+31.8%) |
Sept 2009 | - | -$1.42 M(+16.3%) | -$3.63 M(+64.5%) |
June 2009 | - | -$1.22 M(+24.5%) | -$2.21 M(+118.1%) |
Mar 2009 | - | -$983.00 K(+3325.1%) | -$1.01 M(+265.5%) |
Dec 2008 | -$2.70 M(+874.0%) | - | - |
June 2008 | - | -$28.70 K(-60.8%) | -$276.80 K(+8.5%) |
June 2008 | -$276.80 K(+487.7%) | - | - |
Mar 2008 | - | -$73.30 K(-44.3%) | -$255.20 K(+34.4%) |
Dec 2007 | - | -$131.50 K(+203.7%) | -$189.90 K(+174.4%) |
Sept 2007 | - | -$43.30 K(+509.9%) | -$69.20 K(+46.9%) |
June 2007 | -$47.10 K(-93.6%) | -$7100.00(-11.3%) | -$47.10 K(+7.5%) |
Mar 2007 | - | -$8000.00(-25.9%) | -$43.80 K(-21.6%) |
Dec 2006 | - | -$10.80 K(-49.1%) | -$55.90 K(-80.1%) |
Sept 2006 | - | -$21.20 K(+457.9%) | -$280.50 K(-62.2%) |
June 2006 | -$741.50 K(+62.7%) | -$3800.00(-81.1%) | -$741.50 K(-0.7%) |
Mar 2006 | - | -$20.10 K(-91.5%) | -$746.40 K(-22.2%) |
Dec 2005 | - | -$235.40 K(-51.2%) | -$959.30 K(+13.8%) |
Sept 2005 | - | -$482.20 K(+5442.5%) | -$842.60 K(+84.8%) |
June 2005 | -$455.80 K(-39.2%) | -$8700.00(-96.3%) | -$455.90 K(-27.9%) |
Mar 2005 | - | -$233.00 K(+96.3%) | -$632.70 K(+22.5%) |
Dec 2004 | - | -$118.70 K(+24.3%) | -$516.50 K(-34.0%) |
Sept 2004 | - | -$95.50 K(-48.5%) | -$783.10 K(+4.5%) |
June 2004 | -$749.40 K(+151.7%) | -$185.50 K(+58.8%) | -$749.40 K(+54.8%) |
Mar 2004 | - | -$116.80 K(-69.7%) | -$484.10 K(-1.8%) |
Dec 2003 | - | -$385.30 K(+523.5%) | -$493.10 K(+114.6%) |
Sept 2003 | - | -$61.80 K(-177.4%) | -$229.80 K(-22.8%) |
June 2003 | -$297.70 K(-39.4%) | $79.80 K(-163.4%) | -$297.60 K(+2.7%) |
Mar 2003 | - | -$125.80 K(+3.1%) | -$289.90 K(-2.0%) |
Dec 2002 | - | -$122.00 K(-5.9%) | -$295.80 K(-34.0%) |
Sept 2002 | - | -$129.60 K(-248.1%) | -$448.50 K(-8.7%) |
June 2002 | -$491.20 K(-67.9%) | $87.50 K(-166.4%) | -$491.20 K(-39.8%) |
Mar 2002 | - | -$131.70 K(-52.1%) | -$816.40 K(-6.1%) |
Dec 2001 | - | -$274.70 K(+59.4%) | -$869.30 K(-25.2%) |
Sept 2001 | - | -$172.30 K(-27.5%) | -$1.16 M(-24.1%) |
June 2001 | -$1.53 M(+10.6%) | -$237.70 K(+28.8%) | -$1.53 M(-8.4%) |
Mar 2001 | - | -$184.60 K(-67.5%) | -$1.67 M(-1.3%) |
Dec 2000 | - | -$568.10 K(+5.1%) | -$1.69 M(+11.0%) |
Sept 2000 | - | -$540.70 K(+43.0%) | -$1.53 M(+10.2%) |
June 2000 | -$1.38 M(+38.5%) | -$378.00 K(+83.1%) | -$1.38 M(+25.1%) |
Mar 2000 | - | -$206.50 K(-48.4%) | -$1.11 M(+0.6%) |
Dec 1999 | - | -$400.00 K(0.0%) | -$1.10 M(0.0%) |
Sept 1999 | - | -$400.00 K(+300.0%) | -$1.10 M(+10.0%) |
June 1999 | -$1.00 M(+42.9%) | -$100.00 K(-50.0%) | -$1.00 M(0.0%) |
Mar 1999 | - | -$200.00 K(-50.0%) | -$1.00 M(0.0%) |
Dec 1998 | - | -$400.00 K(+33.3%) | -$1.00 M(+25.0%) |
Sept 1998 | - | -$300.00 K(+200.0%) | -$800.00 K(+14.3%) |
June 1998 | -$700.00 K(+40.0%) | -$100.00 K(-50.0%) | -$700.00 K(-12.5%) |
Mar 1998 | - | -$200.00 K(0.0%) | -$800.00 K(0.0%) |
Dec 1997 | - | -$200.00 K(0.0%) | -$800.00 K(+14.3%) |
Sept 1997 | - | -$200.00 K(0.0%) | -$700.00 K(+40.0%) |
June 1997 | -$500.00 K(-289.8%) | -$200.00 K(0.0%) | -$500.00 K(+66.7%) |
Mar 1997 | - | -$200.00 K(+100.0%) | -$300.00 K(+200.0%) |
Dec 1996 | - | -$100.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) |
Sept 1996 | - | $0.00 | $0.00 |
June 1996 | $263.40 K | - | - |
FAQ
- What is BioCardia annual cash flow from operations?
- What is the all time high annual CFO for BioCardia?
- What is BioCardia annual CFO year-on-year change?
- What is BioCardia quarterly cash flow from operations?
- What is the all time high quarterly CFO for BioCardia?
- What is BioCardia quarterly CFO year-on-year change?
- What is BioCardia TTM cash flow from operations?
- What is the all time high TTM CFO for BioCardia?
- What is BioCardia TTM CFO year-on-year change?
What is BioCardia annual cash flow from operations?
The current annual CFO of BCDA is -$9.97 M
What is the all time high annual CFO for BioCardia?
BioCardia all-time high annual cash flow from operations is $331.00 K
What is BioCardia annual CFO year-on-year change?
Over the past year, BCDA annual cash flow from operations has changed by +$587.00 K (+5.56%)
What is BioCardia quarterly cash flow from operations?
The current quarterly CFO of BCDA is -$2.61 M
What is the all time high quarterly CFO for BioCardia?
BioCardia all-time high quarterly cash flow from operations is $5.57 M
What is BioCardia quarterly CFO year-on-year change?
Over the past year, BCDA quarterly cash flow from operations has changed by -$199.00 K (-8.25%)
What is BioCardia TTM cash flow from operations?
The current TTM CFO of BCDA is -$7.30 M
What is the all time high TTM CFO for BioCardia?
BioCardia all-time high TTM cash flow from operations is $5.71 M
What is BioCardia TTM CFO year-on-year change?
Over the past year, BCDA TTM cash flow from operations has changed by +$3.82 M (+34.32%)